GLP-1 receptor agonists

2 statements across 1 episodes · 1 bullish · 1 bearish · 1 people on the record · first statement May 27, 2025 by Dr. Eric Topol · across every show →

Everything said about GLP-1 receptor agonists, oldest first

May 27, 2025 negative
Assertion Supported
Topol: At least half of patients regain weight after stopping GLP-1s
“We don't have encouraging data at the moment, because at least half of people gain weight back when they stop.”
Dr. Eric Topol May 27, 2025 ▶ 14:06 7 More Healthy Years: What We Can Learn from Super Agers
May 27, 2025 bullish
Opinion
Topol: GLP-1s are the most momentous drug class in medical history
“It's the most momentous drug class in medical history.”
Dr. Eric Topol May 27, 2025 ▶ 11:31 7 More Healthy Years: What We Can Learn from Super Agers
Made with StarZero

Turn any episode into a week of clips.

This entire site, over 1,000 episodes transcribed, diarized, checked and made playable, runs on the StarZero media pipeline. Drop in your own episode and the podcast clipper finds the moments worth sharing, cuts them, captions them, and reframes them for every feed.